Aug 25 (Reuters) - Translate Bio Inc TBIO.O said on Tuesday that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA SASY.PA induced immune response in early-stage non-human primate studies.
In a regulatory filing, the company cited Sanofi's presentation slides showing that the vaccine candidate induced neutralizing antibodies and T-cell responses in animal studies.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)
((email@example.com; +91 8061822700;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.